Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 8—August 2017
Research Letter

Outcomes for 2 Children after Peripartum Acquisition of Zika Virus Infection, French Polynesia, 2013–2014

Marianne BesnardComments to Author , Timothée Dub, and Patrick Gérardin
Author affiliations: Centre Hospitalier de Polynésie Française, Pirae, Tahiti (M. Besnard); Institut Pasteur, Paris, France (T. Dub); Centre Hospitalier Universitaire, Saint Pierre, Réunion (P. Gérardin)

Main Article

Table

Follow-up of liver function test results associated with perinatal Zika virus infection in case-patient 2, French Polynesia, 2014*

Date (postnatal day) AST, U/L† ALT, U/L‡ GGT, U/L§ Bilirubin, total/conjugate, mg/L¶
Feb 4 (2) 84 11 201 158
Feb 6 (4) 38 12 297 145
Feb 10 (8) 52 18 457 128/21
Apr 8 (57) 348 150 281 66/54
Apr 16 (65) 239 139 312 50/42
Apr 30 (79) 117 86 239 10
May 13 (92) 119 104 164 8
Jun 17 (120) 57 51 40 2
Oct 25 (250) 38 47 27 2

*Boldface indicates values out of reference range. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase.
†Reference range 15–40 U/L.
‡Reference range 10–40 U/L.
§Reference range 2–34 U/L.
¶Reference range <14/<3 mg/L.

Main Article

Page created: July 17, 2017
Page updated: July 17, 2017
Page reviewed: July 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external